Biotechnology Nanoparticles $55 Billion Market

Using tiny snippets of DNA as “barcodes,” researchers have developed a new technique for rapidly screening the ability of nanoparticles to selectively deliver therapeutic genes to specific organs of the body. The technique could accelerate the development and use of gene therapies for such killers as heart disease, cancer and Parkinson’s disease writes James Dean @ iHumanMedia.com. 

The cost savings of the noninvasive nanonparticle treatments for the patient and the medical centers is 55% or more on-average. We also find the market for nanoparticles in biotechnology, drug development and drug delivery reaches $55 Billion (2017) with growth of 18% annually for the next 10 years. 

read